As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - rigel pharmaceuticals inc (RIGL)
Nominating Committee* - rigel pharmaceuticals inc (RIGL)
|Name (Connections)||Board Relationships||Title||Key Developments|
|Walter Moos Ph.D.|| 7 Relationships||Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee||Rigel Pharmaceuticals, Inc. Announces Senior Management Promotions|
|Stephen Sherwin M.D.|| 168 Relationships||Director, Chairman of Finance Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee||Daniel Magilavy Joins Rigel as Vice President of Clinical Research|
|Peter Ringrose M.A, Ph.D.|| 74 Relationships||Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee||Rigel Pharmaceuticals Inc. Appoints Bradford S. Goodwin to the Board of Directors and Audit Committee|
Finance Committee* - rigel pharmaceuticals inc (RIGL)
|Debt To Total Capitalization||--|
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
Sponsored Financial Commentaries